Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...
Abstract: The design of subwavelength-scale metamaterials is challenging due to their intricate electromagnetic properties, making traditional simulation approaches computationally intensive and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback